ライフサイエンスコーパス: phakic

1 ter diabetic vitrectomy is high in eyes left phakic.

2 betic vitrectomy may be greater in eyes left phakic.

3 At last follow-up, half of the eyes remained phakic.

4 T1 was 58 years; 50% were male, and 92% were phakic.

5 1.2 (+/- 12.8) years, and 59% (206/351) were phakic.

6 ad at least 2 lines of VA loss, and all were phakic.

7 re of mean age 69 years, 66% female, and 71% phakic.

8 ,231 eyes, 1,212 were pseudophakic and 3,019 phakic, among which 310 had cataract.

9 s of VA gain, of which 30 of 38 (78.9%) were phakic and 22 of 24 (91.7%) were pseudophakic.

10 diagnosis of malignant glaucoma, 5 eyes were phakic and 23 were pseudophakic.

11 ere included in this study; 35% (28/80) were phakic and 34% (27/80) presented with a fovea-on RRD.

12 Fifty-nine eyes were phakic and 58 pseudophakic eyes.

13 nts with insufficient information as well as phakic and Add-on IOLs were excluded.

14 ed in all cases, with minor modifications in phakic and aphakic eyes.

15 ients with diabetes mellitus whose eyes were phakic and had early treatment-naive clinically signific

16 ent after diabetic vitrectomy are similar in phakic and nonphakic eyes.

17 in VIT/RPE-relative intensity values between phakic and pseudophakic eyes (0.3522 vs 0.3577, P = .48)

18 Phakic and pseudophakic eyes were treated with monthly i

19 The increase was observed in both phakic and pseudophakic eyes, suggesting that cataract e

20 A improved in both BRVO and CRVO and in both phakic and pseudophakic eyes.

21 preoperative inclusion criteria, as well as phakic and pseudophakic eyes.

22 at 6 months postoperatively was similar for phakic and pseudophakic FECD eyes (39%; P = .852), but h

23 ween FECD and BK eyes (P = .170), or between phakic and pseudophakic FECD eyes (P = .066) after corre

24 d PPV for RRD repair were estimated for both phakic and pseudophakic or aphakic patients and then wer

25 Phakic and pseudophakic piggyback intraocular lenses are

26 Analysis was divided into phakic and pseudophakic/aphakic patients.

27 st 2 lines of VA gain: 15 of 23 (65.2%) were phakic, and 15 of 15 (100%) were pseudophakic.

28 MHs had at least 2 lines of VA loss: 4 were phakic, and 2 were pseudophakic.

29 nadherence to traditional medical treatment, phakic anterior chamber IOL implantation is currently co

30 Patients who are male, younger, and phakic are at an even higher risk for elevated IOP and p

31 h either gas or SO tamponade was achieved in phakic as well as pseudophakic eyes irrespective of AL o

32 The AREDS participants whose eyes were phakic at baseline and free of late age-related macular

33 compared between phakic eyes (group A), eyes phakic at time of implantation but subsequently underwen

34 oth AU-affected and quiescent fellow-eyes of phakic AU patients with good visual acuity (VA).

35 Among 57 patients (66%) who were phakic before surgery, 52 eyes (91.2%) underwent catarac

36 ween patients in the monofocal IOL group and phakic controls was -0.32 dB (P = .52).

37 n MD between patients in the MFIOL group and phakic controls was -2.40 dB (P < .001) and between pati

38 es that received cataract surgery and in 429 phakic controls: odds ratio (OR) 0.92 (95% CI, 0.77-1.10

39 ing technology, newer IOL models for RLE and phakic correction are becoming available.

40 auses acute intraocular pressure rise in the phakic elderly.

41 caused relative pupillary block similar to a phakic eye and was successfully treated with laser irido

42 Subjects aged 48-65 years with RRD in a phakic eye due to superior retinal tears with an overall

43 Data from the right phakic eye of each participant were used.

44 ilure in 2 eyes (9%), and cataract in 1 of 3 phakic eyes (33%).

45 13 phakic eyes (54%) in the tube group and 9 phakic eyes (43%) in the trabeculectomy group (P = .43).

46 Cataract extraction was performed in 13 phakic eyes (54%) in the tube group and 9 phakic eyes (4

47 ncluded worsening lens opacity in 242 of 443 phakic eyes (55%), loss of >/=3 lines of acuity (Snellen

48 d within 12 months in 13.8% of the initially phakic eyes (95% CI, 11.1-17.2).

49 Outcomes were compared between phakic eyes (group A), eyes phakic at time of implantati

50 onths between the PPV-treated and SB-treated phakic eyes (mean deviation, 0.14; 95% CI, 0.06-0.21; P<

51 d a threefold higher odds of OHT compared to phakic eyes (odds ratio [OR], 3.2; 95% CI: 1.4-9.9; I(2)

52 her rates of delayed retinal detachment than phakic eyes (odds ratio, 1.85 [1.13, 3.04], P = 0.01).

53 us PPV showed greater SOAS than PPV alone in phakic eyes (P < 0.0001), but not in eyes with a posteri

54 Phakic eyes achieved greater surgical success with SB+PP

55 ly to lose 15 or more letters of vision than phakic eyes at 12 months, but not at 24 months.

56 Among the 23 phakic eyes at injection, 30.4% underwent cataract surge

57 Of 4833 phakic eyes at the time of initial RD, 1893 patients (39

58 (median follow-up, 7.1 months); 21.2% of 126 phakic eyes developed cataracts within a year, with 62.8

59 (median follow-up, 6.9 months); 17.9% of 127 phakic eyes developed cataracts within a year, with 63.6

60 The SB-treated phakic eyes had better postoperative BCVA at 6 months or

61 Within 1 year of vitrectomy, 52.1% of phakic eyes had undergone cataract surgery.

62 Within 12 months, among phakic eyes initially >/= 20/40, the incidence of a redu

63 It is possible that phakic eyes may be less prone to severe vision loss.

64 diffractive MFIOL (median age, 64 years), 18 phakic eyes of 18 healthy individuals serving as control

65 atment (MUST) Trial and Follow-up Study, 125 phakic eyes of 74 patients with intermediate, posterior,

66 A retrospective review of phakic eyes that underwent successful RD repair followed

67 Of 12 109 phakic eyes treated for RTs, 1039 eyes (8.6%) underwent

68 During the study period, all phakic eyes ultimately underwent cataract extraction, an

69 Single-operation success for phakic eyes was 64.50% versus 53.93% for pseudophakic ey

70 Retinal reattachment rate in phakic eyes was 94.9% compared to 93.1% in pseudophakic,

71 prevalence of spherical equivalent myopia in phakic eyes was calculated.

72 ly, removal of the clear crystalline lens in phakic eyes was not necessary in the primary interventio

73 Phacovitrectomy was performed in 294 phakic eyes whereas vitrectomy alone in 112 pseudophakic

74 In patients with treatment-naive phakic eyes who had DME, primary therapy with the intrav

75 ound between redetachment rates only between phakic eyes with gas tamponade compared to silicon oil (

76 MT was found in most cases of AU, even in phakic eyes with good VA.

77 Phakic eyes with RD that were successfully repaired with

78 Patients with phakic eyes with RT that were treated successfully with

79 Among eyes free of ML, phakic eyes without cataract rarely (4%) had MT.

80 Phakic eyes without history of any other intraocular sur

81 , 4/65), and cataract progression (12%, 5/41 phakic eyes).

82 a were obtained from 70 subjects with normal phakic eyes, age 9 to 80 years.

83 without epiretinal membrane, eyes with FTMH, phakic eyes, and eyes with a focal VMA </= 1500 mum.

84 residual postoperative air bubble to 30% in phakic eyes, applying a population-specific steroid regi

85 Among initially phakic eyes, cataract and cataract surgery occurred sign

86 Medical treatment was beneficial in phakic eyes, laser hyaloidotomy was beneficial in pseudo

87 ed by 37% 48% in and 43% in MFIOL, MIOL, and phakic eyes, respectively (P < .0001 for each).

88 MFIOL eyes had worse CSF than MIOL and phakic eyes, very possibly due to combined effects of th

89 ary reattachment in the PPV and SB groups in phakic eyes.

90 ripheral image quality compared with that in phakic eyes.

91 ot observed to affect the odds of success in phakic eyes.

92 erior retinal detachment with grade C PVR in phakic eyes.

93 ficantly higher in pseudophakic eyes than in phakic eyes.

94 rates of cataract progression in PPV-treated phakic eyes.

95 , postoperative lens status (adjusted HR vs. phakic eyes: 1.15 for posterior chamber intraocular lens

96 status did not influence DMEK outcomes, for phakic FECD eyes with a still relatively clear crystalli

97 ostoperative period compared to baseline and phakic fellow eyes.

98 63-year-old phakic female who underwent an uneventful phaco-vitrecto

99 Patients who remained unilaterally phakic for at least 24 months after recruitment were inc

100 In the phakic group, there were no significant differences in t

101 These patients were younger and phakic, had floaters from myopic vitreopathy without PVD

102 The risk of RRD in phakic high myopes rose with increasing age.

103 A total of 3159 AREDS2 participants were phakic in at least 1 eye and 1389 of 6027 study eyes und

104 The only phakic individual exhibited white and vacuolated opaciti

105 Of the 6357 LALES participants, 5588 phakic individuals with biometric data were included in

106 27% reduction in fracture risk compared with phakic individuals with cataracts, with 1 less fracture

107 reached the vitreous in pseudophakic but not phakic individuals.

108 a primary surgical intervention may offer a phakic infant with glaucoma an excellent opportunity to

109 Phakic intraocular implants and refractive lens exchange

110 itations; multifocal (diffractive optic) and phakic intraocular lens (IOL) dysphotopsia were excluded

111 garding the incidence and pathophysiology of phakic intraocular lens (pIOL) associated cataracts, sur

112 Phakic intraocular lens (PIOL) implantation has been use

113 rt on the accumulating peer-reviewed data of phakic intraocular lens (pIOL) implantation in the pedia

114 actice in refractive lens exchange (RLE) vs. phakic intraocular lens (pIOL).

115 confirmed the long-term outcomes of the ZB5M phakic intraocular lens (PIOL).

116 treatment, long-term studies of a hyperopic phakic intraocular lens have shown excellent visual outc

117 Phakic intraocular lens implantation (IOLs) and clear le

118 e effective range for surface ablation--need phakic intraocular lens implantation or clear lens extra

119 r the reported efficacy and complications of phakic intraocular lens implantations in children for co

120 , especially in eyes with an angle-supported phakic intraocular lens.

121 two commercially available posterior chamber phakic intraocular lenses (IOLs) using atomic force micr

122 , safety, and stability of Posterior Chamber Phakic Intraocular Lenses (PC-pIOLs) for correcting myop

123 mplantation of 2 types of rigid iris-fixated phakic intraocular lenses (pIOLs) for the treatment of m

124 uss the safety, since their introduction, of phakic intraocular lenses (pIOLs) to correct refractive

125 With continued research and experience, phakic intraocular lenses are becoming an invaluable add

126 Crystalline lens surgery and phakic intraocular lenses are being investigated activel

127 s and marginal outcomes, improved designs of phakic intraocular lenses are providing increasing safet

128 nt smoother anterior surface in the iPCL 2.0 phakic intraocular lenses compared with the VISIAN ICL E

129 ecent advances in the design and material of phakic intraocular lenses have made them very predictabl

130 New applications of phakic intraocular lenses in presbyopia and in other con

131 safety, predictability and visual quality of phakic intraocular lenses make them invaluable for the c

132 demonstrate the superior visual outcomes of phakic intraocular lenses over laser in-situ keratomileu

133 demonstrate the superior visual outcomes of phakic intraocular lenses over other refractive surgerie

134 h high degrees of refractive error, however, phakic intraocular lenses provide superior quality of vi

135 egment anatomy and may allow custom-designed phakic intraocular lenses with proper sizing.

136 g-term complications of different designs of phakic intraocular lenses, such as endothelial cell loss

137 emonstrated the early safety and efficacy of phakic intraocular lenses.

138 stalline lens rise, and the distance between phakic IOL and endothelium were measured.

139 igh myopia implanted with an angle-supported phakic IOL between 1990 and 1996 at Vissum Corporacion O

140 An operation combining phakic IOL removal, DSAEK, cataract removal, and PCIOL i

141 talline lens rise 748.18 +/- 393.13 mum, and phakic IOL-endothelium distance 2.1 +/- 0.30 mm.

142 The implantation of either of the latter two phakic IOLs followed by laser in situ keratomileusis or

143 Iris-fixated and posterior chamber phakic IOLs have proven sufficient safety, but long-term

144 ut the indication to implant angle-supported phakic IOLs in young patients with a long postoperative

145 Trials with angle-supported phakic IOLs revealed unacceptable rates of pupillary ova

146 Four phakic IOLs were used for this prospective, experimental

147 ivo structure and function, with and without phakic lens implants.

148 E-PPV enabled the preservation of the phakic lens in all study patients.

149 ciated with single-procedure success include phakic lens status (P = 0.01), smaller size of retinal d

150 Phakic lens status was the only significant predictor of

151 nts with the FAI, younger age, male sex, and phakic lens status were associated with higher risk of I

152 l VMA, presence of FTMH, absence of ERM, and phakic lens status.

153 collamer lenses (ICLs) are posterior chamber phakic lenses that provide a refractive surgery option f

154 In one phakic member, the cortical cataracts were punctate and

155 For phakic moderately complex primary RRDs in this study of

156 ic eyes showed worse visual acuity (VA) than phakic or pseudophakic eyes.

157 Age, axial length, lens status (phakic or pseudophakic), hypertensive status, ischemic h

158 c eyes, and 4 of the 5 below this limit were phakic (P = .01).

159 89.4% of G1 and 87.5% of G2 were phakic (p = 0.73).

160 Phakic participants aged 40 years who participated in bo

161 logy (ISGEO), during the follow-up period in phakic participants, who did not have the disease at bas

162 Almost all phakic patients in the FAc insert groups developed catar

163 Sixty-five percent of phakic patients in the PPV arm underwent cataract surger

164 se events were reported in 70.3% of baseline phakic patients in the previously treated DEX 0.7 subgro

165 Combined, the incidence rate of RRD in phakic patients in the United States from 2007 to 2016 w

166 The incidence rate of RRD in phakic patients in the United States was 39-fold higher

167 Phakic patients were more likely to experience rejection

168 ar lens (IOL) implantation were performed in phakic patients where media opacity or lens bulging did

169 d ultrasound biomicroscopy (UBM) to evaluate phakic patients with a history of unilateral pars-plana

170 d in subsequent years, then the treatment of phakic patients with DME using ranibizumab may meet acce

171 In treatment of phakic patients with DME, ranibizumab with deferred lase

172 (1) phakic patients with history of pars plana vitrectomy in

173 The cohort of phakic patients with moderately complex RRD was analyzed

174 have the lowest fracture risk compared with phakic patients with or without cataract.

175 SB was used in young phakic patients without posterior vitreous detachment (P

176 y may not affect the integrity of zonules in phakic patients, at least for patients with vitreomacula

177 In phakic patients, final failure rate was lower in the scl

178 7% less expensive than PPV for RRD repair in phakic patients, whereas PPV was 12% less expensive than

179 Cataract progressed in 57% (8/14) of phakic patients, with 63% (5/8) undergoing cataract extr

180 n addition to spherical refractive errors in phakic patients.

181 ificant cataract progression occurred in all phakic patients.

182 t cost savings over PPV for repair of RRD in phakic patients.

183 Achieving precise refractive outcomes in phakic posterior chamber intraocular lens (pIOL) implant

184 This study compares moderately complex phakic primary RRD treated with SB, PPV, or PPV/SB to re

185 Combining phakic, pseudophakic, and aphakic groups, those treated

186 s were maintained at 12 hours in uninflamed, phakic rabbit eyes.

187 al RD was more frequent in pseudophakic than phakic RD eyes (P < .0001).

188 to compare pseudophakic with phakic RD, and phakic RD with and without cataract.

189 Within phakic RD, phakic RD with cataract exhibited several similarities w

190 Phakic RD with cataract shared several features in commo

191 s was performed to compare pseudophakic with phakic RD, and phakic RD with and without cataract.

192 showed significant differences compared with phakic RD, including older age, higher prevalence of mal

193 Within phakic RD, phakic RD with cataract exhibited several sim

194 fered significantly between pseudophakic and phakic RD, with greater occurrence of inferior retinal b

195 Surgical Co, Monrovia, California, USA) and phakic refractive lens (PRL), both for posterior chamber

196 In the treatment of uncomplicated phakic retinal detachments, repair using scleral buckle

197 dia clarity, such as AC cells, AC flare, and phakic status (R(2)-adjusted = 0.424, P < .001).

198 Phakic status and previous vitrectomy surgery do not app

199 is, is independent of pupillary dilation and phakic status of the eye.

200 Goniotomy failure was noncorrelative with phakic status or presence of preoperative synechiae.

201 r preoperative BCVA, smaller iFTMH size, and phakic status were also associated with improved postope

202 erity, subfoveal choroidal thickness [SFCT], phakic status, and best-corrected visual acuity.

203 l thickness by optical coherence tomography, phakic status, number of injections, time to reinjection

204 Clinical data recorded included phakic status, previous vitreoretinal surgery, and anter

205 Phakic subjects 50 years and older were evaluated at a p

206 A total of 2027 phakic subjects aged >=50 years, with no previous histor

207 R) and hazard ratio (HR) of bone fracture in phakic subjects with cataract compared with phakic subje

208 phakic subjects with cataract compared with phakic subjects without cataract and pseudophakic indivi

209 ed OR and HR of fractures compared with both phakic subjects without cataracts (OR: 3.0 [95% credible

210 f PAC disease during the 6-year follow-up in phakic subjects without PAC disease at baseline.

211 dence of late AMD and (2) eyes that remained phakic until study completion.

212 s nontraditional (84.1% vs 74.4%; P = 0.16), phakic versus pseudophakic (79.1% vs 78.0%; P = 0.88), a

213 fferences were seen in mean change in VA for phakic versus pseudophakic eyes.

214 aditional (logMAR 0.21 vs 0.27; P >0.05) and phakic versus pseudophakic groups (logMAR 0.23 vs 0.28;

215 rast to earlier studies, the significance of phakic versus pseudophakic status was not confirmed.

216 evel 1 failure rates when operated eyes were phakic versus pseudophakic.

217 Patients whose eyes were phakic with DME (<3 months) were included if the central

218 , 60 monofocal intraocular lenses [MIOL], 65 phakic) with symptomatic vitreous opacities were enrolle